| 发明名称 |
Use of at least one glycoinhibitor substance |
| 摘要 |
The present invention relates to the use of a glycosidase inhibitor for the manufacture of a medicament for the treatment of a disease, wherein glycosidase enzymes hydrolyze glycoconjugates of a patient to reveal neutral glycan receptors of an pathogenic agent, and wherein the revealed neutral glycan receptor comprise a oligosaccharide sequence.
|
| 申请公布号 |
US2004176320(A1) |
申请公布日期 |
2004.09.09 |
| 申请号 |
US20030482045 |
申请日期 |
2003.12.29 |
| 申请人 |
NATUNEN JARI;MILLER-PODRAZA HALINA;TENEBERG SUSANN;ANGSTROM JONAS;KARLSSON KARL-ANDERS |
发明人 |
NATUNEN JARI;MILLER-PODRAZA HALINA;TENEBERG SUSANN;ANGSTROM JONAS;KARLSSON KARL-ANDERS |
| 分类号 |
A23L1/30;A23L3/3562;A61K8/00;A61K8/60;A61K8/73;A61K31/702;A61K31/7028;A61K31/739;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/02;A61P9/00;A61P11/00;A61P17/00;A61P31/04;A61P31/10;A61P31/12;A61P31/16;A61P35/00;A61P43/00;A61Q11/00;A61Q19/10;C07H7/027;C07H15/10;C12N9/99;(IPC1-7):A61K31/737;C08B37/00 |
主分类号 |
A23L1/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
